Modern antidepressants: Pharmacokinetics, interaction potential and TDM;Moderne antidepressiva: Pharmakokinetik, interaktionspotenzial und TDM

Pharmazie in Unserer Zeit

Volumn 33, Issue 4, 2004, Pages 296-303

  Härtter, Sebastian ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CYTOCHROME P450; DULOXETINE; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MONOAMINE OXIDASE A INHIBITOR; NEUROTRANSMITTER RECEPTOR; PAROXETINE; REBOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADRENERGIC TRANSMISSION; DEPRESSION; DRUG MONITORING; HIPPOCAMPUS; HUMAN; METABOLISM; RATING SCALE; REVIEW;

ANTIDEPRESSIVE AGENTS; DRUG MONITORING; HUMANS;

EID: 4043177688     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200400076     Document Type: Review

References (42)

1. Richelson, E., Mayo Clin Proc 69 (1994), 1069-1081
2. Frazer, A., J Clin Psychopharmacol 17 [suppl1] (1997), 2S-18S
3. Caccia, S., Clin Pharmacokinet 34 (1998), 281-301
4. Hiemke, C., Härtter, S., Pharmacol Ther 85 (2000), 11-28
5. Owens, MJ., Knight, DL., Nemeroff, CB., Biol Psychiatry 50 (2001), 345-350
6. Montgomery, SA., Loft, H., Sanchez C. et al., Pharmacol Toxicol 88 (2001), 282-286
7. Sorba, LA., Revel, L., Martin, L. et al., Drugs of the Future 26 (2001). 115-120
8. Sidhu, J., Preskorn, M., Poulsen, M. et al., Chirality 9 (1997), 686-692
9. st annual NCDEU meeting. Phoenix, Arizona (2001)
10. von Moltke, LL., Greenblatt, DJ., Giancarlo, GM. et al., Drug Metab Dispos 29 (2001) 1102-1109
11. Herrlin, K., Yasui-Furukori, N., Tybring, G. et al., Br J Clin Pharmacol 56 (2003), 415-121
12. Le Bloc'h, Y., Woggon, B., Weissenrieder, H. et al., Ther Drug Monit 25 (2003), 600-608
13. de Boer, T., Ruigt, GSF., CNS Drugs 4 Suppl. 1 (1995), 29-38
14. Leonard, BE., CNS Drugs 54 Suppl. (1993), 3-15
15. Voortman, G., Paanakker, JE., Hum Psychopharmacol 10 Suppl. 2 (1995), S83-S96
16. Timmer, CJ., Paanakker, JE., van Hal, HJM., Hum Psychopharmacol 11 (1996), 497-509
17. Störmer, E., von Moltke, LL., Shader, RI. et al., Drug Metab Dispos 28 (2000), 1168-1175
18. Dahl, M-L., Voortman, G., Elwin, C-E. et al., Clin Drug Invest 13 (1997), 37-46
19. Shams, M., Hiemke, C., Härtter, S., Ther Drug Monit 26 (2004), 78-84
20. Grasmäder K., Dissertationsschrift, Bonn (2003)
21. Wong, EH., Sonders, MS., Amara, SG. et al., Biol Psychiatry 47 (2000), 818-829
22. Kennedy, SH., Lam, RW., Cohen, NL et al., J Psychiatry Neurosci 27 (2002), 418-422
23. Schroeder, C. Tank, J., Boschmann, M. et al., Circulation 105 (2002), 347-353
24. Wienekers, LC., Allievei, C., Hauer, MJ. et al., Drug Metab Dispos 27 (1999), 1334-1340
25. Dostert, P., Benedetti, MS., Poggesi, I., Eur Neuropsychopharmacol 7 Suppl. 1 (1997), S23-S35
26. Tank, J., Schroeder, C., Diedrich, A. et al., Circulation 107 (2003), 2956-2961
27. Sprouse, J., Clarke, T., Reynolds, L. et al., Neuropsychopharmacol 14 (1996), 225-231
28. Kobayashi K., Ishizuka, T., Shimada, N. et al., Drug Metab Dispos 27 (1999), 763-766
29. Sproule, BA., Otton, SV., Cheung, SW. et al., J Clin Psychopharmacol 17 (1997), 102-106
30. Weiss, J., Dormann, S-MG., Martin-Facklam, M. et al., J Pharmacol Exp Ther 305 (2003), 197-204
31. Lundmark, J., Reis, M., Bengstson, F., Ther Drug Monit 22 (2000), 446-454
32. Holliday, SM., Benfield, P., Drugs 49 (1995), 280-293
33. Fogelman, SM., Schmider, J., Venkatakrishnan, K. et al., Neuropsychopharmacol 20 (1999), 480-490
34. Eap, CB., Lessard, E., Baumann, P. et al., Pharmacogenetics 13 (2003), 39-47
35. Lessard, E., Yessine, M-A., Hamelin, BA. et al., Pharmacogenetics 9 (1999), 435-443
36. Buckley, NA., McManus, PR., Brit Med J 325 (2002), 1332-1333
37. Veefkind, AH., Haffmas, PMJ., Heoncamp, E., Ther Drug Monit 22 (2000), 202-208
38. Charlier, C., Pinto, E., Ansseau, M. et al., J Psychopharmacol 16 (2002), 369-372
39. Reis, M., Landmark, J., Björk, H. et al., Ther Drug Monit 24 (2002), 545-553
40. Buller, R., Legrand, V., DDT 6 (2001), 1220-1230
41. Skinner, M., Kuan, H-Y., Pan, A. et al., Clin Pharmacol Ther 73 (2003), 170-177
42. Kirchheiner, J., Klein, C., Meineke, I. et al., Pharmacogenetics 13 (2003), 619-626